Trial intelligence / Profile preview

Pharmacokinetics of Pediatric Aluvia® and Generic Lopinavir/Ritonavir in HIV-1 Infected Thai Adults

NCT01159275Phase 2Completed

Sponsor
HIV-NAT
Start
Jul 2009
Primary completion
Mar 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of lopinavir, ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by HIV-NAT. Started Jul 2009; status: completed.

02

Drugs

lopinavirritonavir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01159275.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01159275.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call